AU748870B2 - Method of inhibiting membrane-type matrix metalloproteinase - Google Patents
Method of inhibiting membrane-type matrix metalloproteinase Download PDFInfo
- Publication number
- AU748870B2 AU748870B2 AU34576/99A AU3457699A AU748870B2 AU 748870 B2 AU748870 B2 AU 748870B2 AU 34576/99 A AU34576/99 A AU 34576/99A AU 3457699 A AU3457699 A AU 3457699A AU 748870 B2 AU748870 B2 AU 748870B2
- Authority
- AU
- Australia
- Prior art keywords
- cmt
- mmp
- tetracycline
- activity
- dimethylamino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/052222 | 1998-03-31 | ||
| US09/052,222 US6277061B1 (en) | 1998-03-31 | 1998-03-31 | Method of inhibiting membrane-type matrix metalloproteinase |
| PCT/US1999/006972 WO1999049871A1 (en) | 1998-03-31 | 1999-03-30 | Method of inhibiting membrane-type matrix metalloproteinase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU3457699A AU3457699A (en) | 1999-10-18 |
| AU748870B2 true AU748870B2 (en) | 2002-06-13 |
Family
ID=21976191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU34576/99A Ceased AU748870B2 (en) | 1998-03-31 | 1999-03-30 | Method of inhibiting membrane-type matrix metalloproteinase |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US6277061B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1079837A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2002509889A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20010042322A (cg-RX-API-DMAC7.html) |
| AU (1) | AU748870B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2320260A1 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ506153A (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999049871A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6506740B1 (en) * | 1998-11-18 | 2003-01-14 | Robert A. Ashley | 4-dedimethylaminotetracycline derivatives |
| EP1174129A1 (en) * | 2000-07-17 | 2002-01-23 | Zenner, Hans Peter, Prof. Dr. med. | Use of a matrix-metalloprotease inhibitor for the treatment of cancer |
| EP1408987B1 (en) | 2001-07-13 | 2013-04-10 | Paratek Pharmaceuticals, Inc. | Tetracycline compounds having target therapeutic activities |
| WO2003030819A2 (en) * | 2001-10-05 | 2003-04-17 | Tetragenex Pharmaceuticals, Inc. | Tetracycline derivatives and methods of use thereof |
| CN100391464C (zh) * | 2001-12-03 | 2008-06-04 | 诺瓦西股份有限公司 | 含活性维生素d化合物的药物组合物 |
| WO2003053447A1 (en) * | 2001-12-20 | 2003-07-03 | Hanauske-Abel Hartmut M | Treatment for averting or delaying premature delivery |
| EP2311797A1 (en) | 2002-01-08 | 2011-04-20 | Paratek Pharmaceuticals, Inc. | 4-dedimethylamino tetracycline compounds |
| JP2005526754A (ja) | 2002-03-08 | 2005-09-08 | パラテック ファーマシューティカルズ インコーポレイテッド | アミノメチル置換されたテトラサイクリン化合物 |
| EP1503981A4 (en) | 2002-03-21 | 2007-08-15 | Paratek Pharm Innc | SUBSTITUTED TETRACYCLINE COMPOUNDS |
| WO2003082011A1 (en) * | 2002-03-29 | 2003-10-09 | The Research Foundation Of State University Of New York | Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins |
| WO2004006850A2 (en) | 2002-07-12 | 2004-01-22 | Paratek Pharmaceuticals, Inc | 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS |
| US20040170621A1 (en) * | 2002-08-30 | 2004-09-02 | Roodman G. David | Method of resisting osteoclast formation |
| US20040138162A1 (en) * | 2002-08-30 | 2004-07-15 | Roodman G. David | Method of resisting osteoclast formation |
| JP4686189B2 (ja) | 2002-10-24 | 2011-05-18 | パラテック ファーマシューティカルズ インコーポレイテッド | Rnaを調節するための置換テトラサイクリン化合物の使用方法 |
| WO2004060346A2 (en) | 2002-12-30 | 2004-07-22 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
| WO2005009943A2 (en) | 2003-07-09 | 2005-02-03 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
| JP4738333B2 (ja) | 2003-07-09 | 2011-08-03 | パラテック ファーマシューティカルズ インコーポレイテッド | 9−アミノメチルテトラサイクリン化合物のプロドラッグ |
| EP2332904A3 (en) * | 2004-01-15 | 2012-04-11 | Paratek Pharmaceuticals, Inc. | Derivatives of tetracycline compounds |
| JP2008518025A (ja) | 2004-10-25 | 2008-05-29 | パラテック ファーマシューティカルズ インコーポレイテッド | 4−アミノテトラサイクリンおよびその使用の方法 |
| WO2006047756A2 (en) | 2004-10-25 | 2006-05-04 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
| CA2616224A1 (en) * | 2005-07-21 | 2007-02-01 | Paratek Pharmaceuticals, Inc. | 10-substituted tetracyclines and methods of use thereof |
| US20070142337A1 (en) * | 2005-12-15 | 2007-06-21 | The Regents Of The University Of California | Treatment of inflammation and organ dysfunction |
| PL2120963T3 (pl) | 2006-12-21 | 2019-05-31 | Paratek Pharm Innc | Podstawione związki tetracyklinowe do leczenia zaburzeń zapalnych skóry |
| IL270446B2 (en) * | 2006-12-21 | 2023-10-01 | Paratek Pharm Innc | A tetracycline compound, a pharmaceutical preparation containing the tetracycline compound, and the tetracycline compound or the pharmaceutical preparation for the treatment of the tetracycline-responsive condition |
| EP2144870A2 (en) * | 2007-04-27 | 2010-01-20 | Paratek Pharmaceuticals, Inc. | Methods for synthesizing and purifying aminoalkyl tetracycline compounds |
| WO2009009042A1 (en) * | 2007-07-06 | 2009-01-15 | Paratek Pharmaceuticals, Inc. | Methods for synthesizing substituted tetracycline compounds |
| TWI585071B (zh) | 2008-05-19 | 2017-06-01 | 派洛泰克藥物股份有限公司 | 四環素化合物之甲苯磺酸鹽及同素異形體 |
| HUE026562T2 (hu) | 2008-08-08 | 2016-06-28 | Tetraphase Pharmaceuticals Inc | C7-fluor-helyettesített tetraciklin vegyületek |
| CN102459153A (zh) | 2009-05-08 | 2012-05-16 | 四相制药公司 | 四环素类化合物 |
| EP2470500B1 (en) | 2009-08-28 | 2017-10-04 | Tetraphase Pharmaceuticals, Inc. | Tetracycline compounds |
| WO2011123536A1 (en) | 2010-03-31 | 2011-10-06 | Tetraphase Pharmaceuticals, Inc. | Polycyclic tetracycline compounds |
| LT2707003T (lt) | 2011-05-12 | 2019-10-10 | Paratek Pharmaceuticals, Inc. | Kristalinės (4s,4as,5ar,12as)-4-dimetilamino-3,10,12,12a-tetrahidroksi-7-[(metoksi(metil)amino)-metil]-1,11-diokso-1,4,4a,5,5a,6,11,12a-oktahidro-naftacen-2-karboksirūgšties amido druskos ir jų panaudojimo būdai |
| TR201902057T4 (tr) | 2012-08-31 | 2019-03-21 | Tetraphase Pharmaceuticals Inc | Tetrasiklin bileşikleri. |
| MA46567A (fr) | 2016-10-19 | 2019-08-28 | Tetraphase Pharmaceuticals Inc | Formes cristallines de l'éravacycline |
| WO2020097450A1 (en) | 2018-11-09 | 2020-05-14 | Tetraphase Pharmaceuticals, Inc. | Polymorphic forms of a compound and uses thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992012717A2 (en) * | 1991-01-15 | 1992-08-06 | A composition containing a tetracycline and use for inhibiting angiogenesis |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4704383A (en) * | 1983-12-29 | 1987-11-03 | The Research Foundation Of State University Of New York | Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same |
| US4925833A (en) * | 1983-12-29 | 1990-05-15 | The Research Foundation Of State University Of New York | Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis |
| JPH06256280A (ja) * | 1992-11-17 | 1994-09-13 | Univ New York State | 糖尿病における過度のコラーゲン架橋結合を阻害する非抗菌性化学修飾テトラサイクリンを含むテトラサイクリン |
| US5668122A (en) * | 1993-07-28 | 1997-09-16 | Fife; Rose S. | Method to treat cancer with tetracyclines |
| GB9615976D0 (en) | 1996-07-30 | 1996-09-11 | Center For Clinical & Basic Re | The use of proteinase inhibitors for the prevention or reduction of bone resorption |
| US5789395A (en) * | 1996-08-30 | 1998-08-04 | The Research Foundation Of State University Of New York | Method of using tetracycline compounds for inhibition of endogenous nitric oxide production |
| US5837696A (en) | 1997-01-15 | 1998-11-17 | The Research Foundation Of State University Of New York | Method of inhibiting cancer growth |
-
1998
- 1998-03-31 US US09/052,222 patent/US6277061B1/en not_active Expired - Lifetime
-
1999
- 1999-03-30 EP EP99916213A patent/EP1079837A4/en not_active Withdrawn
- 1999-03-30 NZ NZ506153A patent/NZ506153A/en unknown
- 1999-03-30 WO PCT/US1999/006972 patent/WO1999049871A1/en not_active Ceased
- 1999-03-30 AU AU34576/99A patent/AU748870B2/en not_active Ceased
- 1999-03-30 JP JP2000540834A patent/JP2002509889A/ja not_active Abandoned
- 1999-03-30 CA CA002320260A patent/CA2320260A1/en not_active Abandoned
- 1999-03-30 KR KR1020007010871A patent/KR20010042322A/ko not_active Ceased
-
2001
- 2001-05-14 US US09/855,067 patent/US20020045603A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992012717A2 (en) * | 1991-01-15 | 1992-08-06 | A composition containing a tetracycline and use for inhibiting angiogenesis |
Also Published As
| Publication number | Publication date |
|---|---|
| NZ506153A (en) | 2003-10-31 |
| AU3457699A (en) | 1999-10-18 |
| US6277061B1 (en) | 2001-08-21 |
| US20020045603A1 (en) | 2002-04-18 |
| WO1999049871A8 (en) | 1999-12-02 |
| CA2320260A1 (en) | 1999-10-07 |
| JP2002509889A (ja) | 2002-04-02 |
| WO1999049871A1 (en) | 1999-10-07 |
| EP1079837A4 (en) | 2003-07-02 |
| EP1079837A1 (en) | 2001-03-07 |
| KR20010042322A (ko) | 2001-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6277061B1 (en) | Method of inhibiting membrane-type matrix metalloproteinase | |
| AU729886B2 (en) | Method of inhibiting cancer growth | |
| ES2241124T3 (es) | Actividad inhibidora de serin-proteinasa mediante tetraciclina hidrofoba. | |
| ES2237945T3 (es) | Combinacion de bisfosfonato y tetraciclina. | |
| Davies et al. | A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts | |
| Johnson et al. | Matrix metalloproteinases | |
| JP2676080B2 (ja) | 非抗バクテリア性テトラサイクリン組成物 | |
| ES2578618T3 (es) | Composiciones que comprenden proteasa, amilasa y lipasa para su uso en el tratamiento de infecciones por Staphylococcus aureus | |
| DE69322659T2 (de) | Pharmazeutische zubereitung enthaltend eine beta-lactam antibiotikum abbauende verbindung, und deren verwendung | |
| Lee et al. | CMT-3, a non-antimicrobial tetracycline (TC), inhibits MT1-MMP activity: relevance to cancer | |
| US6429204B1 (en) | Method of inhibiting cancer growth | |
| EP0871438B1 (en) | Use of alpha-hydroxy acids in the manufacture of a medicament for the treatment of inflammation | |
| Hanemaaijer et al. | Inhibition of matrix metalloproteinases (MMPs) by tetracyclines | |
| Schneider et al. | Tetracyclines inhibit intracellular muscle proteolysis in vitro | |
| Rathna et al. | Recent Insights of Matrix Metalloproteinase Inhibitors in Therapeutic Applications | |
| MXPA99006554A (en) | Method of inhibiting cancer growth | |
| Acid | Correlation of Antiangiogenic and Antitumor Efficacy of | |
| Konttinen et al. | Inhibition of matrix metalloproteinases (MMPs) by tetracyclines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| SREP | Specification republished | ||
| TH | Corrigenda |
Free format text: IN VOL 16, NO 18, PAGE(S) 4707 UNDER THE HEADING APPLICATIONS ACCEPTED UNDER THE NAME THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, SERIAL NO. 748870, INID (72), ADD INVENTORS LEE, H-M., SORSA, T., TERONEN, O., SALO, T. |
|
| FGA | Letters patent sealed or granted (standard patent) |